These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 8340529)
21. The nuclear pore complex protein Tpr is a common autoantigen in sera that demonstrate nuclear envelope staining by indirect immunofluorescence. Ou Y; Enarson P; Rattner JB; Barr SG; Fritzler MJ Clin Exp Immunol; 2004 May; 136(2):379-87. PubMed ID: 15086405 [TBL] [Abstract][Full Text] [Related]
22. Anti-NOR 90. A new autoantibody in scleroderma that recognizes a 90-kDa component of the nucleolus-organizing region of chromatin. Rodriguez-Sanchez JL; Gelpi C; Juarez C; Hardin JA J Immunol; 1987 Oct; 139(8):2579-84. PubMed ID: 3309055 [TBL] [Abstract][Full Text] [Related]
23. Antibodies in scleroderma: direct pathogenicity and phenotypic associations. Chung L; Utz PJ Curr Rheumatol Rep; 2004 Apr; 6(2):156-63. PubMed ID: 15016347 [TBL] [Abstract][Full Text] [Related]
25. Immunolocalization and partial characterization of a nucleolar autoantigen (PM-Scl) associated with polymyositis/scleroderma overlap syndromes. Reimer G; Scheer U; Peters JM; Tan EM J Immunol; 1986 Dec; 137(12):3802-8. PubMed ID: 3537125 [TBL] [Abstract][Full Text] [Related]
26. Circulating Fc gamma receptor-specific autoantibodies in localized and systemic scleroderma. Davis K; Boros P; Keltz M; Unkeless JC; Fleischmajer R J Am Acad Dermatol; 1995 Oct; 33(4):612-6. PubMed ID: 7673494 [TBL] [Abstract][Full Text] [Related]
27. Antibody specificities of Thai and Australian scleroderma sera with topoisomerase I recombinant fusion proteins. Cram DS; Fisicaro N; McNeilage LJ; Coppel RL; Harrison LC J Immunol; 1993 Dec; 151(12):6872-81. PubMed ID: 7505017 [TBL] [Abstract][Full Text] [Related]
28. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies. Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135 [TBL] [Abstract][Full Text] [Related]
29. Presence of anti-eukaryotic initiation factor-2B, anti-RuvBL1/2 and anti-synthetase antibodies in patients with anti-nuclear antibody negative systemic sclerosis. Pauling JD; Salazar G; Lu H; Betteridge ZE; Assassi S; Mayes MD; McHugh NJ Rheumatology (Oxford); 2018 Apr; 57(4):712-717. PubMed ID: 29294089 [TBL] [Abstract][Full Text] [Related]
30. Heterogenous nuclear RNP C1 and C2 core proteins are targets for an autoantibody found in the serum of a patient with systemic sclerosis and psoriatic arthritis. Stanek D; Vencovský J; Kafková J; Raska I Arthritis Rheum; 1997 Dec; 40(12):2172-7. PubMed ID: 9416854 [TBL] [Abstract][Full Text] [Related]
31. Self-reactive repertoire of tight skin (TSK/+) mouse: immunochemical and molecular characterization of anti-cellular autoantibodies. Muryoi T; André-Schwartz J; Saitoh Y; Daian C; Hall B; Dimitriu-Bona A; Schwartz RS; Bona CA; Kasturi KN Cell Immunol; 1992 Oct; 144(1):43-54. PubMed ID: 1382866 [TBL] [Abstract][Full Text] [Related]
40. Autoantibodies to the Rpp25 component of the Th/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests. Mahler M; Satoh M; Hudson M; Baron M; Chan JY; Chan EK; Wick J; Fritzler MJ; J Rheumatol; 2014 Jul; 41(7):1334-43. PubMed ID: 24931955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]